Literature DB >> 20962112

Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure.

Sarah C Clayton1, Karla K V Haack, Irving H Zucker.   

Abstract

Excessive sympathetic drive is a hallmark of chronic heart failure (HF). Disease progression can be correlated with plasma norepinephrine concentration. Renal function is also correlated with disease progression and prognosis. Because both the renal nerves and renin-angiotensin II system are activated in chronic HF we hypothesized that excessive renal sympathetic nerve activity decreases renal blood flow in HF and is associated with changes in angiotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor (AT2R) expression. The present study was carried out in conscious, chronically instrumented rabbits with pacing-induced HF. We found that rabbits with HF showed a decrease in mean renal blood flow (19.8±1.6 in HF vs. 32.0±2.5 ml/min from prepace levels; P<0.05) and an increase in renal vascular resistance (3.26±0.29 in HF vs. 2.21±0.13 mmHg·ml(-1)·min in prepace normal rabbits; P<0.05) while the blood flow and resistance was not changed in HF rabbits with the surgical renal denervation. Renal AT1R expression was increased by ∼67% and AT2R expression was decreased by ∼87% in rabbits with HF; however, kidneys from denervated rabbits with HF showed a near normalization in the expression of these receptors. These results suggest renal sympathetic nerve activity elicits a detrimental effect on renal blood flow and may be associated with alterations in the expression of angiotensin II receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962112      PMCID: PMC3023215          DOI: 10.1152/ajprenal.00088.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  55 in total

1.  ANG II type 2 receptors and neural control of intrarenal blood flow.

Authors:  Niwanthi W Rajapakse; Gabriela A Eppel; Robert E Widdop; Roger G Evans
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07-20       Impact factor: 3.619

Review 2.  Role of adenosine antagonism in the cardiorenal syndrome.

Authors:  Mustafa M Dohadwala; Michael M Givertz
Journal:  Cardiovasc Ther       Date:  2008       Impact factor: 3.023

3.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2009-01-27       Impact factor: 29.690

4.  Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons.

Authors:  Dongmei Liu; Lie Gao; Shyamal K Roy; Kurtis G Cornish; Irving H Zucker
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

5.  Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats.

Authors:  Shun-Guang Wei; Yang Yu; Zhi-Hua Zhang; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

6.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

7.  Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction.

Authors:  Timothy E Lindley; David W Infanger; Mark Rishniw; Yi Zhou; Marc F Doobay; Ram V Sharma; Robin L Davisson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-29       Impact factor: 3.619

8.  Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure.

Authors:  Lie Gao; Wei Wang; Dongmei Liu; Irving H Zucker
Journal:  Circulation       Date:  2007-06-04       Impact factor: 29.690

Review 9.  Management of the cardiorenal syndrome in heart failure.

Authors:  Jigar Patel; J Thomas Heywood
Journal:  Curr Cardiol Rep       Date:  2006-05       Impact factor: 2.931

Review 10.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

View more
  34 in total

1.  What is the benefit of renal denervation?

Authors:  Takuya Kishi
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

2.  Renal nerves dynamically regulate renal blood flow in conscious, healthy rabbits.

Authors:  Alicia M Schiller; Peter R Pellegrino; Irving H Zucker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

Review 3.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

4.  Exercise training attenuates chemoreflex-mediated reductions of renal blood flow in heart failure.

Authors:  Noah J Marcus; Carolin Pügge; Jai Mediratta; Alicia M Schiller; Rodrigo Del Rio; Irving H Zucker; Harold D Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-22       Impact factor: 4.733

Review 5.  Organ selective regulation of sympathetic outflow by the brain Angiotensin system.

Authors:  Rohit Ramchandra; Song T Yao; Clive N May
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

6.  Renal sympathetic denervation in resistant hypertension.

Authors:  Mário Santos; Henrique Carvalho
Journal:  World J Cardiol       Date:  2013-04-26

Review 7.  Renal denervation: intractable hypertension and beyond.

Authors:  Wassawon Ariyanon; Huijuan Mao; Zelal Adýbelli; Silvia Romano; Mariapia Rodighiero; Bernhard Reimers; Luigi La Vecchia; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-01-15       Impact factor: 2.041

Review 8.  Renal Denervation in Heart Failure.

Authors:  Michael W Fong; David Shavelle; Fred A Weaver; Mitra K Nadim
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

9.  Unilateral renal denervation improves autonomic balance in conscious rabbits with chronic heart failure.

Authors:  Alicia M Schiller; Karla K V Haack; Peter R Pellegrino; Pamela L Curry; Irving H Zucker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-04       Impact factor: 3.619

10.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.